Updated September 2026Oral is the cheaper routeRevel Health review
The tablet undercuts the injection on both molecules, which is the reverse of the usual order.
The verdict
Revel Health prices its oral dissolving tablet below its own injection on both molecules: $149 against $199 for semaglutide, $199 against $249 for tirzepatide. Each line also opens with a reduced first month.
Disclosure: This GLP is reader-supported. Some links below are affiliate links — if you start care through them we may earn a commission, at no extra cost to you. The order on this page is not commercial, and a commission never changes what we write about a provider. How we make money.
- Category
- GLP-1 telehealth
- Molecule
- Semaglutide · Tirzepatide
- Form
- Injection
- Dose pricing
- Flat across doses
- States
- 45
- From
- $149/mo
- Prescription
- Required
- Compounded
- Yes — not FDA-approved
Revel Health sells compounded semaglutide and compounded tirzepatide in two forms each, through an online service covering forty-five states. Injectable semaglutide is advertised at $199 a month and injectable tirzepatide at $249. The oral dissolving tablets are $149 and $199. Every line carries a lower first month: $99, $149, $99 and $149 respectively.
Who writes the prescription, and what do they see?
Treatment is arranged remotely and a prescription precedes shipping. Revel states that the rate covers consultation, medication, supplies and shipping. That is a claim about what is bundled, not a description of who conducts the consultation or what it involves.
The service runs at a distance and every product is compounded. What distinguishes it is the direction of its own pricing. Most sellers charge a premium for an oral, on the reasoning that a daily tablet is the convenience option. Revel charges less for it, so a reader choosing the tablet here is not paying for the preference.
What happens when the dose goes up?
The rates are stated as flat across doses. Escalation over the first sixteen weeks is the normal path, so a flat rate holds the monthly figure through the part that usually moves it. The seller does not describe what clinical support accompanies a step.
What the price includes
The first-month figures are the part to read carefully. A reader comparing $99 against a competitor's standing rate is comparing one month against twelve. On the injection the difference is $100 in month one and nothing thereafter, so the annual figure is $2,388 for semaglutide rather than the $1,188 a $99 rate would imply. The all-in claim covers consultation, medication, supplies and shipping, which is a wider bundle than most sellers state.
What it claims, and what it cites
Every product is compounded, prepared by a pharmacy rather than manufactured and reviewed as a finished product. A compounded semaglutide is not FDA-approved and is not assessed for safety, efficacy or quality before dispensing. The published trial evidence for these molecules was generated with the approved products at labeled doses.
Where it holds up, and where it does not
- Strength: Oral priced below the injection on both molecules
- Strength: Rate stated to include consultation and shipping
- Strength: All four combinations carry a published figure
- Limitation: Headline first-month rates apply once
- Limitation: Five states are not served
- Limitation: Support at a dose step is not described
What the evidence says about this kind of treatment
The assessment above is about Revel Health. These are about the drugs it sells, and they are traced to the primary literature.
- Right for
- A reader who wants an oral and expects to pay less for it, which on this seller is what happens.
- Wrong for
- A reader comparing on a first-month figure, which is not what the following eleven months cost.
How Revel Health compares
| Seller | Who it suits | Go |
|---|---|---|
| DoctorAdam | A reader weighing a tablet against an injection who wants the decision to be about the routine rather than the cost. | See DoctorAdam → |
| Zera Health | A reader who reads the dose qualifier before the figure, since the $129 line is described as low-dose rather than as the standing rate. | See Zera Health → |
| Alan Meds | A reader starting on injectable semaglutide who wants a low rate that is stated to hold as the dose climbs. | See Alan Meds → |
More GLP-1 telehealth sellers reviews: Idgie HealthKERNX HealthLean MedsLibertyMaximusNextMeds
Sponsored alternative
Synergy Rx
A reader who wants the oral and injectable rates for both molecules stated up front rather than after an intake form.
Check Synergy Rx availability →Frequently asked
- Why is the tablet cheaper than the injection here?
- That is how Revel prices it. The oral dissolving tablet is $149 against $199 for injectable semaglutide, and $199 against $249 on tirzepatide.
- What does the first-month price mean?
- It applies to the first month only. Injectable semaglutide opens at $99 and then runs at $199, so a twelve-month course is $2,288 rather than twelve times either figure.
- What is included in the rate?
- Revel states that consultation, medication, supplies and shipping are covered. That is a broader bundle than most sellers describe, and it is the seller's own claim.
- Is Revel Health expensive compared with other GLP-1 telehealth sellers?
- Revel Health publishes a starting figure of $149/mo. Across the 32 GLP-1 telehealth sellers we review that publish a single monthly figure, those run $76 to $299 with a median of $139, which puts Revel Health above the median. A starting figure is not a bill — labs, consultations and shipping are often charged separately, so confirm what your own quote includes.